Slingshot members are tracking this event:
Rheumatoid Arthritis, Phase 2a data due 1H 2021.
- Source Link:
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jan 19, 2021
- Discussing the Phase 2a data on Aclaris' MK2 inhibitor, ATI-450, in treating Rheumatoid Arthritis ACRS Executed On: Feb 03, 2021 at 01:00 PM EST
Related Keywords Rheumatoid Arthritis, Best